TransMedics (TMDX) Capital Expenditures Growth (3y) (2021 - 2026)
TransMedics (TMDX) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.69 Bn | 175.40 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.07 Bn | 98.85 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 67.93 Bn | 66.47 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.11 Bn | 44.44 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 0.84% |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.60 Bn | 1.98 Bn | 7.57% |
| 8 | Smith & Nephew | 26.99 Bn | 26.42 Bn | - | - |
| 9 | Koninklijke Philips | 24.05 Bn | 20.92 Bn | 2.07 Bn | 2.15% |
| 10 | TransMedics | 2.56 Bn | 2.10 Bn | 101.16 Mn | 240.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 240.69% |
| Dec 31, 2025 | 77.72% |
| Sep 30, 2025 | 77.53% |
| Jun 30, 2025 | -315.39% |
| Mar 31, 2025 | 206.50% |
| Dec 31, 2024 | -237.69% |
| Sep 30, 2024 | 1,089.45% |
| Jun 30, 2024 | -451.75% |
| Mar 31, 2024 | 1,747.92% |
| Dec 31, 2023 | 607.29% |
| Sep 30, 2023 | 6.80% |
| Jun 30, 2023 | -136.15% |
| Mar 31, 2023 | 102.28% |
| Dec 31, 2022 | 232.78% |
| Sep 30, 2022 | 379.26% |
| Jun 30, 2022 | 76.81% |
| Mar 31, 2022 | 93.80% |
| Dec 31, 2021 | 187.28% |
| Sep 30, 2021 | -34.36% |
| Mar 31, 2021 | -44.07% |